2,694
Views
8
CrossRef citations to date
0
Altmetric
Commentary

Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management?

, MDORCID Icon, , MD, , MD, , MDORCID Icon, , MDORCID Icon, , MD & , MDORCID Icon show all
Pages 991-994 | Received 23 Mar 2020, Accepted 29 May 2020, Published online: 22 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jorge Maspero, Juana Pavie, Carlos A. Torres-Duque, Felicia Montero-Arias, Ruth Cerino-Javier, Francisco Rovira & Maarten J. H. I. Beekman. (2023) Toward a better understanding of severe asthma phenotypes in Latin America: results from the PREPARE study. Current Medical Research and Opinion 39:4, pages 627-638.
Read now
Felicia Montero-Arias, Jose Carlos Herrera Garcia, Manuel Pacheco Gallego, Martti Anton Antila, Patricia Schonffeldt, Walter Javier Mattarucco, Luis Fernando Tejado Gallegos & Maarten J. H. I. Beekman. (2023) Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study. Journal of Asthma 60:3, pages 574-587.
Read now
John Carlos Pedrozo-Pupo, Manuel Conrado Pacheco Gallego, Iván de Jesús Baños Álvarez, Rodolfo Antonio Jaller Raad, Andrea Carolina Caballero Pinilla, Humberto Reynales Londoño, Laura Bernal Villada & Maarten Beekman. (2022) A Cross-Sectional Study on Prescription Patterns of Short-Acting β2-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort. Journal of Asthma and Allergy 15, pages 1167-1178.
Read now

Articles from other publishers (5)

O. Mendoza-Cano & E. Murillo-Zamora. (2024) Assessing the asthma-related burden of disease in Latin American and Caribbean countries: a sociodemographic perspective. Public Health 227, pages 163-168.
Crossref
Martti Anton Antila1, Adelmir Souza-Machado2,4, Marcelo Gervilla Gregório3, Álvaro A Cruz4,5, Luciene Angelini6, Maarten J H I Beekman7, Gilmar Alves Zonzin8 & Marcelo Fouad Rabahi9. (2024) Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil. Jornal Brasileiro de Pneumologia, pages e20230174.
Crossref
Philip J. Cooper, Camila A. Figueiredo, Alejandro Rodriguez, Leticia Marques dos Santos, Rita C. Ribeiro‐Silva, Valdirene Leao Carneiro, Gustavo Costa, Thiago Magalhães, Talita dos Santos de Jesus, Raimon Rios, Hugo Bernardino F. da Silva, Ryan Costa, Martha E. Chico, Maritza Vaca, Neuza Alcantara‐Neves, Laura C Rodrigues, Alvaro A. Cruz & Mauricio L. Barreto. (2023) Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme. Clinical and Translational Allergy 13:3.
Crossref
Chih-Cheng Lai, Chao-Hsien Chen, Ya-Hui Wang, Cheng-Yi Wang & Hao-Chien Wang. (2022) The impact of the overuse of short-acting β2-agonists on the risk of sepsis and septic shock. Journal of Allergy and Clinical Immunology 150:1, pages 75-81.e1.
Crossref
Eric D. Bateman, David B. Price, Hao-Chien Wang, Patricia Schonffeldt, Angelina Catanzariti, Ralf J.P. van der Valk & Maarten J.H.I. Beekman. (2022) Reply to: Cause or consequence?. European Respiratory Journal 59:6, pages 2200103.
Crossref